Cme Group Inc. · NASDAQ:CME

Cme — Q1 2026 Earnings Presentation

11 slides from Cme's earnings presentation, Apr 22, 2026

  1. Slide 1: 1Q 2026 Earnings Commentary

    1Q 2026 Earnings Commentary (unaudited) Notes • All references to “options” or “options contracts” in the text of this document refer to options on futures contracts. “Futures and options” is often simplified to F&O throughout. Short Term Interest Rate products are simplified to STIR and Long Term I

  2. Slide 2: 1Q 2026 Earnings Summary

    1Q 2026 Earnings Summary1 CME Group’s strong performance in 1Q26 generated the best quarter in the company’s history Revenue, Adjusted Operating Expense and ● Revenue up 14% to a record $1.9 billion Adjusted Diluted Earnings Per Share (EPS) ● Market data revenue up 15% to a record $224 million ● Rec

  3. Slide 3: Record ADV across all asset classes contributed to 14% year-over-year revenue growth

    Record ADV across all asset classes contributed to 14% year-over-year revenue growth Record level revenue is aided by the effectiveness of our volume tiers which help our customers cost effectively manage their risk exposure in high volume times - volume executed at these higher tiers remains very p

  4. Slide 4: Accelerating market data demand and all-time high non-U.S. activity also contributed to record financial results

    Accelerating market data demand and all-time high non-U.S. activity also contributed to record financial results Record quarterly Market Data revenue increased Highest Non-U.S. quarterly ADV increased 30% to 11.4 million in 1Q26 15% to $224 million in 1Q26 ● All-time high quarterly ADV across all re

  5. Slide 5: 1Q 2026 Financials ADV Highlights and Longer-Term Trends

    1Q 2026 Financials ADV Highlights and Longer-Term Trends ● 1Q26 Financials ADV up 18% from 1Q25 to 28.5 million (millions) Interest Rates F&O (millions) Equity Index ○ Record Treasury F&O ADV of 10.6 million and record SOFR F&O Annual ADV Annual ADV 8.7 18.7 ADV of 7.5 million ○ Interest Rates optio

  6. Slide 6: 1Q 2026 Commodities ADV Highlights and Longer-Term Trends

    WTI Crude Oil ADV 1Q 2026 Commodities ADV Highlights and Longer-Term Trends (millions) ● Higher priced Commodities products driving more of the YoY growth in 1Q26, up 38% from 1Q25 to 7.7 2.1 million, and represented 21% of total volume and 36% of clearing and transaction fee revenue ○ Record quarte

  7. Slide 7: During 1Q26, the company continued to advance several longer-term innovative initiatives

    During 1Q26, the company continued to advance several longer-term innovative initiatives related to expanding our customer base and increasing trading and risk management opportunities for market participants DTCC and CME Group received regulatory approvals to Making Cryptocurrency F&O Continue to a

  8. Slide 8: New products and services innovation has been a hallmark of CME Group's strategy

    New products and services innovation has been a hallmark of CME Group’s strategy Bringing our global participants and next generation traders the necessary tools to effectively manage risk and capture opportunities as markets evolve quickly - more granularity in F&O products provide precision and ac

  9. Slide 9: 1Q26 Financial Results

    1Q26 Financial Results Dividends Paid (millions) ● 1Q26 revenue was a record $1.9 billion, up ● The adjusted 1Q26 effective 14% versus 1Q25. 1Q26 clearing and tax rate was 23.6% transaction fee revenue totaled a record $1.5 billion, including ~$77 million of ● Adjusted net income was transaction rev

  10. Slide 10: Financial Results: Appendix – Micro Product Quarterly Details

    Financial Results: Appendix – Micro Product Quarterly Details ADV in thousands / RPC in cents Micro Equity Index Products (including Micro Crypto) 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25 1Q26 ADV 2,336 2,487 2,945 2,486 3,502 3,607 2,693 3,574 4,154 RPC 30.7 29.9 29.8 31.4 31.0 31.3 31.3 30.2 30.3 %

  11. Slide 11: Use of Non-GAAP Measures, Forward-looking Statements, Q&A, Conference Call Details

    Use of Non-GAAP Measures A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart within the financial statements posted on the Investor Relations page on CME Group’s Web site at www.cmegroup

CME Group — Q1 2026 Earnings Presentation on 6ix